ArticleJPRAS open2022
Primary Lymphomas of the Breast: A Review.
Article in JPRAS open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.Breast (Edinburgh, Scotland) · 2022Guideline
- Clinical Outcomes of Breast-Involved Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Real-World Study with Insights into CNS Prophylaxis.Current oncology (Toronto, Ont.) · 2026Article
- High-grade, poorly differentiated breast carcinoma mimicking primary breast lymphoma: a case report of a diagnostic dilemma.Annals of medicine and surgery (2012) · 2026Article
- Primary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology.Blood research · 2026Article
- Primary breast diffuse large B-cell lymphoma mimicking breast carcinoma: a diagnostic challenge - case report.International journal of surgery case reports · 2026Article
- Breast Lymphoma: Rare Mimicker of Breast Cancer.Indian dermatology online journal · 2026Article
- Rarity to Remission: Complete Response of Primary Breast Diffuse Large B-Cell Lymphoma With Chemoimmunotherapy.Clinical case reports · 2026Article
- Primary Breast Lymphoplasmacytic Lymphoma in a Young Woman: A Rare Case of Waldenström's Disease.Cureus · 2025Article
- Initial local treatment strategies on survival outcomes of early-stage breast mucosa-associated lymphoid tissue lymphoma.Annals of hematology · 2025Article
- Article
- Clinical and pathological features of lymphomas in the breast: a comprehensive multicentric study.Scientific reports · 2025Article
- Article
- Primary Breast Extranodal Marginal Zone Lymphoma: A Case Report and Brief Review of the Literature.Clinical case reports · 2025Article
- Bilateral breast swelling in a pregnant woman with high-grade B-cell lymphoma, potentially Burkitt lymphoma.Radiology case reports · 2025Article
- Contrast-enhanced ultrasound diagnosis and efficacy prediction of primary breast lymphoma: a case report and literature review.Frontiers in oncology · 2025Article
- Primary diffuse large B-cell lymphoma of the breast with rare growth pattern mimics lobular carcinoma: a case report.Frontiers in oncology · 2025Article
- Rare Breast Cancers Review.Healthcare (Basel, Switzerland) · 2024Review
- A Rare Case of Diffuse Large B-cell Lymphoma in the Breast: Diagnostic Insights and Treatment Approaches.Cureus · 2024Article
- Article
- Secondary Breast Burkitt Lymphoma Involving the Stomach, Ovary, Pancreas, and Bones: A Case Report.Journal of the Korean Society of Radiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule. Here, we discuss the clinical presentations, histological and immunohistochemical features and treatment options for each type of primary breast lymphoma. We hope that this review will highlight the importance of the timely and accurate diagnosis of breast lymphoma in order to tailor the most appropriate treatment. We also wish to raise awareness of the breast implant-associated lymphomas, with the goal of stimulating work that will aid our understanding of their epidemiology and pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.